Localization of cellular changes within multimodal sensory regions in aged monkey brain: Possible implications for age-related cognitive loss☆

1980 ◽  
Vol 1 (1) ◽  
pp. 45-52 ◽  
Author(s):  
K BRIZZEE ◽  
J ORDY ◽  
R BARTUS
2003 ◽  
Vol 24 (5) ◽  
pp. 745-752 ◽  
Author(s):  
Kazunori Kawamura ◽  
Yuichi Kimura ◽  
Hideo Tsukada ◽  
Tadayuki Kobayashi ◽  
Shingo Nishiyama ◽  
...  
Keyword(s):  

2019 ◽  
Vol 116 (52) ◽  
pp. 26239-26246 ◽  
Author(s):  
Danielle Beckman ◽  
Sean Ott ◽  
Kristine Donis-Cox ◽  
William G. Janssen ◽  
Eliza Bliss-Moreau ◽  
...  

As the average age of the population continues to rise, the number of individuals affected with age-related cognitive decline and Alzheimer’s disease (AD) has increased and is projected to cost more than $290 billion in the United States in 2019. Despite significant investment in research over the last decades, there is no effective treatment to prevent or delay AD progression. There is a translational gap in AD research, with promising drugs based on work in rodent models failing in clinical trials. Aging is the leading risk factor for developing AD and understanding neurobiological changes that affect synaptic integrity with aging will help clarify why the aged brain is vulnerable to AD. We describe here the development of a rhesus monkey model of AD using soluble oligomers of the amyloid beta (Aβ) peptide (AβOs). AβOs infused into the monkey brain target a specific population of spines in the prefrontal cortex, induce neuroinflammation, and increase AD biomarkers in the cerebrospinal fluid to similar levels observed in patients with AD. Importantly, AβOs lead to similar dendritic spine loss to that observed in normal aging in monkeys, but so far without detection of amyloid plaques or tau pathology. Understanding the basis of synaptic impairment is the most effective route to early intervention and prevention or postponement of age-related cognitive decline and transition to AD. These initial findings support the use of monkeys as a platform to understand age-related vulnerabilities of the primate brain and may help develop effective disease-modifying therapies for treatment of AD and related dementias.


Primates ◽  
2004 ◽  
Vol 45 (3) ◽  
Author(s):  
Nobuyuki Kimura ◽  
Shin?ichiro Nakamura ◽  
Fumiko Ono ◽  
Ippei Sakakibara ◽  
Yoshiyuki Ishii ◽  
...  

2012 ◽  
Vol 33 (1) ◽  
pp. 200.e23-200.e31 ◽  
Author(s):  
Bang-Bon Koo ◽  
Steven P. Schettler ◽  
Donna E. Murray ◽  
Jong-Min Lee ◽  
Ronald J. Killiany ◽  
...  

1989 ◽  
Vol 10 (1) ◽  
pp. 11-19 ◽  
Author(s):  
Gary L. Wenk ◽  
Donna J. Pierce ◽  
Robert G. Struble ◽  
Donald L. Price ◽  
Linda C. Cork

PLoS ONE ◽  
2021 ◽  
Vol 16 (7) ◽  
pp. e0254806
Author(s):  
Kelly Rafferty ◽  
Kellie J. Archer ◽  
Kristi Turner ◽  
Ruth Brown ◽  
Colleen Jackson-Cook

Down syndrome, which results from a trisomic imbalance for chromosome 21, has been associated with 80+ phenotypic traits. However, the cellular changes that arise in somatic cells due to this aneuploid condition are not fully understood. The primary aim of this study was to determine if germline trisomy 21 is associated with an increase in spontaneous somatic cell chromosomal instability frequencies (SCINF). To achieve this aim, we quantified SCINF in people with mosaic Down syndrome using a cytokinesis-blocked micronucleus assay. By comparing values in their isogenic trisomic/disomic cells, we obtained a measure of differences in SCINF that are directly attributable to a trisomy 21 imbalance, since differential effects attributable to “background” genetic factors and environmental exposures could be eliminated. A cross-sectional assessment of 69 people with mosaic Down syndrome (ages 1 to 44; mean age of 12.84 years) showed a significantly higher frequency of micronuclei in their trisomic (0.37 ± 0.35 [mean ± standard deviation]) compared to disomic cells (0.18 ± 0.11)(P <0.0001). The daughter binucleates also showed significantly higher levels of abnormal patterns in the trisomic (1.68 ± 1.21) compared to disomic (0.35 ± 0.45) cells (P <0.0001). Moreover, a significant Age x Cell Type interaction was noted (P = 0.0113), indicating the relationship between age and SCINF differed between the trisomic and disomic cells. Similarly, a longitudinal assessment (mean time interval of 3.9 years; range of 2 to 6 years) of 18 participants showed a mean 1.63-fold increase in SCINF within individuals over time for their trisomic cells (P = 0.0186), compared to a 1.13-fold change in their disomic cells (P = 0.0464). In summary, these results showed a trisomy 21-associated, age-related increase in SCINF. They also underscore the strength of the isogenic mosaic Down syndrome model system for “unmasking” cellular changes arising from a trisomy 21 imbalance.


1996 ◽  
Vol 17 (4) ◽  
pp. S199
Author(s):  
C.I. Fernández ◽  
O. González ◽  
L. Alvarez ◽  
L. Zulueta ◽  
E. Fermin ◽  
...  

2001 ◽  
Vol 922 (1) ◽  
pp. 30-41 ◽  
Author(s):  
Nobuyuki Kimura ◽  
Shin-ichiro Nakamura ◽  
Toshiyuki Honda ◽  
Akihiko Takashima ◽  
Hiroyuki Nakayama ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document